Literature DB >> 15173473

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

Rebecca L Koscik1, Philip M Farrell, Michael R Kosorok, Kathleen M Zaremba, Anita Laxova, Hui-Chuan Lai, Jeff A Douglas, Michael J Rock, Mark L Splaingard.   

Abstract

OBJECTIVE: Patients who have cystic fibrosis (CF) and experience delayed diagnosis by traditional methods have greater nutritional insult compared with peers diagnosed via neonatal screening. The objective of this study was to evaluate cognitive function in children with CF and the influence of both early diagnosis through neonatal screening and the potential effect of early malnutrition.
METHODS: Cognitive assessment data were obtained for 89 CF patients (aged 7.3-17 years) during routine clinic visits. Patients had been enrolled in either the screened (N = 42) or traditional diagnosis (control) group (N = 47) of the Wisconsin CF Neonatal Screening Project. The Test of Cognitive Skills, Second Edition was administered to generate the Cognitive Skills Index (CSI) and cognitive factor scores (Verbal, Nonverbal, and Memory).
RESULTS: Cognitive scores in the overall study population were similar to normative data (CSI mean [standard deviation]: 102.5 [16.6]; 95% confidence interval: 99.1-105.9). The mean (standard deviation) CSI scores for the screened and control groups were 104.4 (14.4) and 99.8 (18.5), respectively. Significantly lower cognitive scores correlated with indicators of malnutrition and unfavorable family factors such as single parents, lower socioeconomic status, and less parental education. Our analyses revealed lower cognitive scores in patients with low plasma alpha-tocopherol (alpha-T) levels at diagnosis. In addition, patients in the control group who also had vitamin E deficiency at diagnosis (alpha-T < 300 microg/dl) showed significantly lower CSI scores in comparison with alpha-T-sufficient control subjects and both deficient and sufficient alpha-T subsets of screened patients.
CONCLUSION: Results suggest that prevention of prolonged malnutrition by early diagnosis and nutritional therapy, particularly minimizing the duration of vitamin E deficiency, is associated with better cognitive functioning in children with CF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173473     DOI: 10.1542/peds.113.6.1549

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Extra corporeal membrane oxygenation (ECMO) therapy in a 3-year-old child with cystic fibrosis: a tale of hope.

Authors:  Patrick Stafler; Colin Wallis
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

2.  Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

Authors:  Sarah A Jadin; Grace S Wu; Zhumin Zhang; Suzanne M Shoff; Benjamin M Tippets; Philip M Farrell; Tami Miller; Michael J Rock; Hara Levy; HuiChuan J Lai
Journal:  Am J Clin Nutr       Date:  2011-03-23       Impact factor: 7.045

3.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

4.  Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.

Authors:  Don B Sanders; Huichuan J Lai; Michael J Rock; Philip M Farrell
Journal:  J Cyst Fibros       Date:  2011-11-21       Impact factor: 5.482

Review 5.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

6.  Psychological, cognitive and maternal stress assessment in children with primary ciliary dyskinesia.

Authors:  Marco Carotenuto; Maria Esposito; Francesca Di Pasquale; Sara De Stefano; Francesca Santamaria
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

7.  Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Authors:  Oranan Siwamogsatham; Wei Dong; Jose N Binongo; Ritam Chowdhury; Jessica A Alvarez; Shawna J Feinman; Jessica Enders; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2014-04-17       Impact factor: 3.080

8.  Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter Study.

Authors:  Christine Coburn-Miller; Susan Casey; Quynh Luong; Natalia Cameron; Jasna Hocevar-Trnka; Daniel H Leung; Daniel Gelfond; James E Heubi; Bonnie Ramsey; Drucy Borowitz
Journal:  Clin Transl Sci       Date:  2015-06-05       Impact factor: 4.689

9.  Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention.

Authors:  Chiara Bertolaso; Veronique Groleau; Joan I Schall; Asim Maqbool; Maria Mascarenhas; Norma E Latham; Kelly A Dougherty; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-04       Impact factor: 2.839

10.  Cystic fibrosis: benefits and clinical outcome.

Authors:  K O McKay
Journal:  J Inherit Metab Dis       Date:  2007-07-06       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.